Effects of Empagliflozin on Left Ventricular Remodeling in Patients with Type 2 Diabetes and Coronary Artery Disease: Echocardiographic Substudy of the EMPA-HEART CardioLink-6 Randomized Clinical Trial

K Bami; S Gandhi; H Leong-Poi; AT Yan; E Ho; M Zahrani; V Garg; F Zuo; H Teoh; A Quan; LA Leiter; RE Gilbert; B Zinman; KE Thorpe; P Jüni; CD Mazer; S Verma; G Ong; KA Connelly

Journal article

Effects of Empagliflozin on Left Ventricular Remodeling in Patients with Type 2 Diabetes and Coronary Artery Disease: Echocardiographic Substudy of the EMPA-HEART CardioLink-6 Randomized Clinical Trial

K Bami, S Gandhi, H Leong-Poi, AT Yan, E Ho, M Zahrani, V Garg, F Zuo, H Teoh, A Quan, LA Leiter, RE Gilbert, B Zinman, KE Thorpe, P Jüni, CD Mazer, S Verma, G Ong, KA Connelly

Journal of the American Society of Echocardiography | MOSBY-ELSEVIER | Published : 2020

DOI: 10.1016/j.echo.2020.02.005

University of Melbourne Researchers

Richard Gilbert Author

Grants

Funding Acknowledgements

This trial was supported by an unrestricted investigator-initiated study grant from Boehringer Ingelheim to Drs. Verma and Zinman. The study sponsor was not involved in the study design; data collection, analysis, and interpretation; the writing of this report; or the decision to submit for publication.